Model Parameter Results

Estimated HGF parameters for 124 participants.<br>x.DrugID gives the row-wise drug identifier for each participant, where:1 = Placebo2 = DA-3 = ACh-4 = NA-<br>x.DeltaAlertness and x.BodyWeight were used as covariates in the analyses.<br>Alpha1 trajectories 30 trials either side of true contextual change-points are provided for the 32 participants from the Placebo group. These trajectories are categorised according to three types of transition matrix switch:1. 0th order to 0th order (x.PlaceboAlpha1_ZeroOrdertoZeroOrder)2. 0th order to 1st order (x.PlaceboAlpha1_ZeroOrdertoFirstOrder)3. 0th order to Alternating (x.PlaceboAlpha1_ZeroOrdertoAlternating)<br>Data are participant x trial from outcome (-30 to 30).